Premium
Impact of nationwide health insurance coverage for non‐invasive prenatal testing
Author(s) -
Vinante Valentina,
Keller Bettina,
Huhn Evelyn A.,
Huang Dorothy,
Lapaire Olav,
ManegoldBrauer Gwendolin
Publication year - 2018
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12422
Subject(s) - medicine , obstetrics , gynecology , prenatal screening , aneuploidy , singleton , health insurance , pregnancy , demography , prenatal diagnosis , fetus , health care , chromosome , biochemistry , biology , sociology , gene , economics , genetics , economic growth , chemistry
Objective To describe the changes in women's choices for prenatal testing after the introduction of nationwide health insurance coverage for non‐invasive prenatal testing ( NIPT ) in Switzerland. Methods The present retrospective study reviewed data from all women with singleton pregnancies who presented at the prenatal unit of Basel University Hospital, Switzerland, for first‐trimester screening between July 15, 2014, and December 31, 2015. Women were divided into three categories according to their risk for aneuploidy, and the uptake of NIPT in the period before and after the introduction of the nationwide coverage for NIPT was compared. Results Overall, 887 women were included in the study: 573 screens were carried out before (group 1) and 314 after (group 2) the introduction of insurance coverage for NIPT . In group 1, 53 (9.2%) had NIPT as compared with 72 (22.9%) in group 2. Among women with intermediate risk for aneuploidies and basic insurance coverage, NIPT increased by 56% (12/88 [14%] vs 32/46 [70%]; P <0.001). Conclusion There was a notable increase in the uptake of NIPT ; uptake was most significant among women with basic health insurance and intermediate risk for aneuploidy.